iGEM’s Post

Granza Bio grabs $7.14M seed from Felicis and Y Combinator to advance delivery of cancer treatments. The team is revolutionising the way therapeutic cargo like cancer treatments and genetic medicines is delivered to specific tissues, modelled from our body’s attack particles. Read more about their seed round and other synbio news from around the world on our website: https://lnkd.in/dHhFPx55 Ashwin Jainarayanan, one of the co-founders of Granza Bio, was the team lead for the 2018 IISER Mohali iGEM Team and also a member of our Academia & Research Topic group. #iGEM #SynBio #BiotechNews